Home > News > Chicago's future as a tech center in jeopardy
August 7th, 2009
Chicago's future as a tech center in jeopardy
Parlaying local knowledge into the next big thing becomes tougher given the increasing complexity of today's scientific ventures, said Arthur, who explores the subject in a new book, "The Nature of Technology." Developing nanotechnology, for instance, requires collective willpower, industrial might and plenty of cash, as well as native expertise.
By many measures, Chicago has a long way to go.
Fragmented as ever, Chicago has plenty of bets, from nanotechnology and clean energy to biotech and material science. "We have some extraordinary assets," O'Connor said. "They haven't coalesced."
News and information
Leti Presentation at IEDM 2013 Will Report Phase-Change Memory Developments for Microcontroller Embedded Applications December 7th, 2013
Leti Announces Update of UTSOI Model that Allows Designers To Improve Trade-Off between Performance and Power Use December 7th, 2013
Steve Janack to Join Behan Communications and Lead Firm’s New Innovation Practice Group December 7th, 2013
Optical Quality Improvement of Electrical Circuits’ Electrode Zinc Oxide Nanowires December 7th, 2013
Cutting Away at the NRC's Research Capability December 6th, 2013
Project aims to mass-produce 'nanopetals' for sensors, batteries October 22nd, 2013
Governor Cuomo Announces 'Nano Utica' $1.5 Billion Public-Private Investment That Will Make the Mohawk Valley New York's Next Major Hub of Nanotech Research October 12th, 2013
SUNY CNSE to Develop Marcy Nanocenter Site for 450mm Computer Chip Manufacturing: Building on Governor Cuomo’s CNSE G450C initiative and expanded partnership between NanoCollege and the Mohawk Valley EDGE continues New York’s investment strategy September 12th, 2013
Harris & Harris Group Notes ABSMaterials' Series B Financing November 22nd, 2013
Harris & Harris Group Letter to Shareholders on Website November 18th, 2013
Harris & Harris Group Reports Financial Statements as of September 30, 2013 November 12th, 2013
Harris & Harris Group Notes CordenPharma's Acquisition of Ancora's Carbohydrate Synthesis Platform and Corporate Name November 7th, 2013